OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CXCR4 as a novel target in immunology: moving away from typical antagonists
Birgit Caspar, Pietro Cocchiara, Armelle Melet, et al.
Future Drug Discovery (2022) Vol. 4, Iss. 2
Open Access | Times Cited: 16

Showing 16 citing articles:

Targeting immune cell recruitment in atherosclerosis
Yvonne Döring, Emiel P. C. van der Vorst, Christian Weber
Nature Reviews Cardiology (2024) Vol. 21, Iss. 11, pp. 824-840
Closed Access | Times Cited: 18

Structural insights into CXCR4 modulation and oligomerization
Kei Saotome, Luke L. McGoldrick, Jo-Hao Ho, et al.
Nature Structural & Molecular Biology (2024)
Open Access | Times Cited: 11

CXCR4: from B-cell development to B cell–mediated diseases
Stéphane Giorgiutti, Julien Rottura, Anne‐Sophie Korganow, et al.
Life Science Alliance (2024) Vol. 7, Iss. 6, pp. e202302465-e202302465
Open Access | Times Cited: 9

Structural insights into CXCR4 modulation and oligomerization
Kei Saotome, Luke L. McGoldrick, Jo-Hao Ho, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4

Identification and catalogue of viral transcriptional regulators in human diseases
Citu Citu, Le Chang, Astrid M. Manuel, et al.
iScience (2025) Vol. 28, Iss. 3, pp. 112081-112081
Open Access

Cutting-Edge Treatment Strategies for Dry Eye Disease: Current Status and Future Perspectives
楠 马
Advances in Clinical Medicine (2025) Vol. 15, Iss. 04, pp. 355-361
Closed Access

Sorafenib—Drug Delivery Strategies in Primary Liver Cancer
Piotr Szyk, Beata Czarczyńska-Goślińska, Marta Ziegler-Borowska, et al.
Journal of Functional Biomaterials (2025) Vol. 16, Iss. 4, pp. 148-148
Open Access

Toll-like Receptor Response to Human Immunodeficiency Virus Type 1 or Co-Infection with Hepatitis B or C Virus: An Overview
Mohammad Enamul Hoque Kayesh, Michinori Kohara, Kyoko Tsukiyama–Kohara
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9624-9624
Open Access | Times Cited: 7

Discovery of Bis-Imidazoline Derivatives as New CXCR4 Ligands
Zhicheng Zhou, Isabelle Staropoli, Anne Brelot, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1156-1156
Open Access | Times Cited: 4

Lipidation of a bioactive cyclotide-based CXCR4 antagonist greatly improves its pharmacokinetic profile in vivo
Dipankar Chaudhuri, Tiangong Lu, Binu Jacob, et al.
Journal of Controlled Release (2023) Vol. 359, pp. 26-32
Open Access | Times Cited: 4

Exploring the potential of phytoconstituents from Phaseolus vulgaris L against C-X-C motif chemokine receptor 4 (CXCR4): a bioinformatic and molecular dynamic simulations approach
Cesarius Singgih Wahono, Mokhamad Fahmi Rizki Syaban, Mirza Zaka Pratama, et al.
Egyptian Journal of Medical Human Genetics (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1

Novel Anti-Enterovirus A71 Compounds Discovered by Repositioning Antivirals from the Open-Source MMV Pandemic Response Box
Nattinee Lochaiyakun, Potjanee Srimanote, Onruedee Khantisitthiporn, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 785-785
Open Access

IS4FAM, a fluorescent tool to study CXCR4 affinity and competitive antagonism in native cancer cells
Isabel Hamshaw, Marco M. D. Cominetti, Princess Nana‐Akyin, et al.
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 5
Open Access

Identification and catalogue of viral transcriptional regulators in human diseases
Citu Citu, Le Chang, Astrid M. Manuel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Repeated CXCR4 Blockade by Plerixafor Attenuates Transplant Vasculopathy in Murine Aortic Allografts
F. Theil, A. Kuckhahn, André Hörning, et al.
The Journal of Immunology (2024) Vol. 213, Iss. 10, pp. 1542-1552
Closed Access

Page 1

Scroll to top